Invention Grant
- Patent Title: Heterocyclic compounds as PI3K-γ inhibitors
-
Application No.: US17356984Application Date: 2021-06-24
-
Publication No.: US11773102B2Publication Date: 2023-10-03
- Inventor: Artem Shvartsbart , Stacey Shepard , Andrew P. Combs , Lixin Shao , Nikoo Falahatpisheh , Ge Zou , Andrew W. Buesking , Richard B. Sparks , Eddy W. Yue , Ravi Kumar Jalluri
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- The original application number of the division: US16045358 2018.07.25
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K31/519 ; A61P17/06 ; A61P35/02 ; A61P37/06 ; A61P35/04 ; A61P19/02 ; C07D487/04 ; C07D519/00
Abstract:
This application relates to compounds of Formula (I):
or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Public/Granted literature
- US20230009843A1 HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS Public/Granted day:2023-01-12
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
